Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
58.8 |
% |
58.8 |
% |
PO, oral; |
DRUGBANK |
T Max |
0.75 |
h |
0.75(0.5-4) |
h |
Oral single dose; |
DRUGBANK |
T Max |
1.0 |
h |
1(1-1.2) |
h |
intravenous injection, IV; |
DRUGBANK |
Tss |
1.0 |
h |
1(0.5-6) |
h |
Oral single dose; |
DRUGBANK |
Tss |
1.0 |
h |
1 |
h |
intravenous injection, IV; |
DRUGBANK |
Clearance |
16.3 |
L/h |
16.3 |
L/h |
Average clearance; |
DRUGBANK |
Clearance |
0.14 |
L/h/kg |
2.33 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
39.0 |
L |
30-48 |
L |
Steady state volume of distribution; |
DRUGBANK |
Volume of Distribution |
0.35 |
L/kg |
0.35 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
3.7 |
h |
3.7 |
h |
elimination half-life; |
DRUGBANK |
Half-life |
6.4 |
h |
4.2-8.5 |
h |
elimination half-life; Oral multiple dose; |
DRUGBANK |
Half-life |
2.1 |
h |
2.1 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
28.0 |
% |
28 |
% |
Faeces excretion; Unchanged drug; |
DRUGBANK |
Protein Binding |
84.0 |
% |
84 |
% |
plasma proteins; human, homo sapiens; |
DRUGBANK |